The FIGO ovulatory disorders classification system

Ovulatory disorders are common causes of amenorrhea, abnormal uterine bleeding, and infertility, and are frequent manifestations of polycystic ovary syndrome (PCOS). There are many potential causes and contributors to ovulatory dysfunction that challenge clinicians, trainees, educators, and those who perform basic, translational, clinical, and epidemiological research. Similarly, therapeutic approaches to ovulatory dysfunction potentially involve a spectrum of lifestyle, psychological, medical, and procedural interventions. Collaborative research, effective education, and consistent clinical care remain challenged by the absence of a consensus comprehensive system for classification of these disorders. The existing and complex system, attributed to WHO, was developed more than three decades ago and did not consider more than 30 years of research into these disorders in addition to technical advances in imaging and endocrinology. This manuscript describes the development of a new classification of ovulatory disorders performed under the aegis of the International Federation of Gynecology and Obstetrics (FIGO) and conducted using a rigorously applied Delphi process. The stakeholder organizations and individuals who participated in this process comprised specialty journals, experts at large, national, specialty obstetrical and gynecological societies, and informed lay representatives. After two face‐to‐face meetings and five Delphi rounds, the result is a three‐level multi‐tiered system. The system is applied after a preliminary assessment identifies the presence of an ovulatory disorder. The primary level of the system is based on an anatomic model (Hypothalamus, Pituitary, Ovary) that is completed with a separate category for PCOS. This core component of the system is easily remembered using the acronym HyPO‐P. Each anatomic category is stratified in the second layer of the system to provide granularity for investigators, clinicians, and trainees using the “GAIN‐FIT‐PIE” mnemonic (Genetic, Autoimmune, Iatrogenic, Neoplasm; Functional, Infectious and Inflammatory, Trauma and Vascular; Physiological, Idiopathic, Endocrine). The tertiary level allows for specific diagnostic entities. It is anticipated that, if widely adopted, this system will facilitate education, clinical care, and the design and interpretation of research in a fashion that better informs progress in this field. Integral to the deployment of this system is a periodic process of reevaluation and appropriate revision, reflecting an improved understanding of this collection of disorders.

[1]  C. R. Giviziez,et al.  Association of Overweight and Consistent Anovulation among Infertile Women with Regular Menstrual Cycle: A Case-control Study , 2021, Revista Brasileira de Ginecologia e Obstetricia / RBGO - Gynecology and Obstetrics.

[2]  Canquan Zhou,et al.  Impact of Luteinized Unruptured Follicles on Clinical Outcomes of Natural Cycles for Frozen/Thawed Blastocyst Transfer , 2021, Frontiers in Endocrinology.

[3]  Fertility evaluation of infertile women: a committee opinion. , 2021, Fertility and sterility.

[4]  E. Balman,et al.  National Institute for Health and Care Excellence (NICE) , 2017, The Grants Register 2022.

[5]  S. Fleming,et al.  A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors , 2020, Clinical endocrinology.

[6]  Infertility Workup for the Women's Health Specialist: ACOG Committee Opinion, Number 781. , 2019, Obstetrics and gynecology.

[7]  M. Munro,et al.  The two FIGO systems for normal and abnormal uterine bleeding symptoms and classification of causes of abnormal uterine bleeding in the reproductive years: 2018 revisions , 2018, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[8]  Rong Li,et al.  Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome , 2018, Fertility and sterility.

[9]  A. Berry,et al.  There might be blood: a scoping review on women’s responses to contraceptive-induced menstrual bleeding changes , 2018, Reproductive Health.

[10]  R. Pierson,et al.  Follicle growth and endocrine dynamics in women with spontaneous luteinized unruptured follicles versus ovulation , 2018, Human reproduction.

[11]  H. Teede,et al.  The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. , 2016, Human reproduction update.

[12]  Committee Opinion No. 651 Summary: Menstruation in Girls and Adolescents Using the Menstrual Cycle as a Vital Sign , 2015, Obstetrics and gynecology.

[13]  M. Naess,et al.  Ovulation Prevalence in Women with Spontaneous Normal-Length Menstrual Cycles – A Population-Based Cohort from HUNT3, Norway , 2015, PloS one.

[14]  Liccardo Pacula,et al.  RAND Corporation , 2015 .

[15]  R. Norman,et al.  Definition and significance of polycystic ovarian morphology: a task force report from the Androgen Excess and Polycystic Ovary Syndrome Society. , 2014, Human reproduction update.

[16]  Optimizing natural fertility: a committee opinion. , 2013, Fertility and sterility.

[17]  P. Crosignani,et al.  Health and fertility in World Health Organization group 2 anovulatory women. , 2012, Human reproduction update.

[18]  Enrico Carmina,et al.  Consensus on women's health aspects of polycystic ovary syndrome (PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group. , 2012, Fertility and sterility.

[19]  M. Broder,et al.  An international response to questions about terminologies, investigation, and management of abnormal uterine bleeding: use of an electronic audience response system. , 2011, Seminars in reproductive medicine.

[20]  M. Broder,et al.  FIGO classification system (PALM‐COEIN) for causes of abnormal uterine bleeding in nongravid women of reproductive age , 2011, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

[21]  H. Burger,et al.  Atypical estradiol secretion and ovulation patterns caused by luteal out-of-phase (LOOP) events underlying irregular ovulatory menstrual cycles in the menopausal transition , 2009, Menopause.

[22]  H. Burger,et al.  Cycle and hormone changes during perimenopause: the key role of ovarian function , 2008, Menopause.

[23]  M. Broder,et al.  Can we achieve international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding? , 2007, Human reproduction.

[24]  Hilary O D Critchley,et al.  A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. , 2007, Fertility and sterility.

[25]  M. Blythe,et al.  Menstruation in Girls and Adolescents: Using the Menstrual Cycle as a Vital Sign , 2006, Pediatrics.

[26]  Z. Amarin,et al.  Luteinized unruptured follicle syndrome: incidence and recurrence rate in infertile women with unexplained infertility undergoing intrauterine insemination. , 2006, Human reproduction.

[27]  A. Balen The pathophysiology of polycystic ovary syndrome: trying to understand PCOS and its endocrinology. , 2004, Best practice & research. Clinical obstetrics & gynaecology.

[28]  Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. , 2004, Fertility and sterility.

[29]  M. Hickey,et al.  Menstrual disorders in adolescence: investigation and management. , 2003, Human reproduction update.

[30]  D. Cumming,et al.  Does Anovulation Exist in Eumenorrheic Women? , 2003, Obstetrics and gynecology.

[31]  R. Azziz,et al.  Idiopathic hirsutism: an uncommon cause of hirsutism in Alabama. , 1998, Fertility and sterility.

[32]  A. Pinol,et al.  Menstrual bleeding patterns in untreated women , 1997 .

[33]  A. Pinol,et al.  Menstrual bleeding patterns in untreated women. Task Force on Long-Acting Systemic Agents for Fertility Regulation. , 1997, Contraception.

[34]  P. J. Rowe,et al.  WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple , 1993 .

[35]  R. Frisch Body fat, menarche, fitness and fertility. , 1987, Human reproduction.

[36]  Worldhealthorganizationtaskfo World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girlsII. Longitudinal study of menstrual patterns in the early postmenarcheal period, duration of bleeding episodes and menstrual cycles , 1986 .

[37]  Worldhealthorganizationtaskfo World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girlsI. A multicenter cross-sectional study of menarche , 1986 .

[38]  M. Arny,et al.  Inaccuracy of basal body temperature charts in predicting urinary luteinizing hormone surges. , 1986, Fertility and sterility.

[39]  World Health Organization multicenter study on menstrual and ovulatory patterns in adolescent girls. I. A multicenter cross-sectional study of menarche. World Health Organization Task Force on Adolescent Reproductive Health. , 1986, Journal of adolescent health care : official publication of the Society for Adolescent Medicine.

[40]  R. Largo,et al.  Menstrual patterns in adolescent Swiss girls: a longitudinal study. , 1984, Annals of human biology.

[41]  J. Bauman,et al.  Basal body temperature: unreliable method of ovulation detection. , 1981, Fertility and sterility.

[42]  E. Beutner,et al.  Report of a WHO Scientific Group (Part 3 of 3) , 1973 .

[43]  Agents stimulating gonadal function in the human. Report of a WHO scientific group. , 1973, World Health Organization technical report series.

[44]  A. Treloar,et al.  Variation of the human menstrual cycle through reproductive life. , 1967, International journal of fertility.

[45]  J. Perich [Menstrual cycle]. , 1950, Journal des praticiens; revue generale de clinique et de therapeutique.